Newsroom

Title
MegaPro Biomedical has performed brilliantly, and the rapid development process of the developer product has been approved by the US FDA to enter the clinical phase II trial
Global Bio & Investment Interview with Dr. Jassy Wang, General Manager of MegaPro Biomedical
2017 Taiwan Biotechnology Industry Future Summit
Interview with Focus Reports
MegaPro Biomedical Wins the 13th National Innovation Award - Startup Award